You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult acute myeloid leukemia with 11q23 (MLL) abnormalities

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial (biological, drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • aldesleukin
  • +9 more
  • (no location specified)
Feb 17, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +44 more
  • fludarabine phosphate
  • +9 more
  • Duarte, California
  • +6 more
Sep 6, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +77 more
  • fludarabine phosphate
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 16, 2019

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • sargramostim
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2022

Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional

Completed
  • Acute Myeloid Leukemia
  • Conventional Cytogenetics Studies
  • +2 more
  • Assiut, Egypt
    South Egypt Cancer Institute
Mar 7, 2022

Frequency and Risk Factors of Acute Myeloid Leukemia

Not yet recruiting
  • Myeloid Leukemia
  • Bone marrow aspirite for diagnosis
  • (no location specified)
Mar 15, 2023

Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia Trial in Canada, Puerto Rico, United

Completed
Has Results
  • Acute Myeloid Leukemia
  • +27 more
  • Caspofungin Acetate
  • +2 more
  • Birmingham, Alabama
  • +178 more
Mar 26, 2021

Multidrug Resistance Genes in Acute Myeloid Leukemia

Active, not recruiting
  • Leukemia
  • gene expression analysis
  • +4 more
  • Fort Wayne, Indiana
    Fort Wayne Medical Oncology and Hematology
Aug 16, 2021

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +17 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 27, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • metformin hydrochloride
  • +2 more
  • Chicago, Illinois
    Northwestern University
Jan 8, 2019

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid

Completed
Has Results
  • Adult Acute Erythroid Leukemia (M6)
  • +15 more
  • liposomal cytarabine-daunorubicin CPX-351
  • Stanford, California
    Stanford University, School of Medicine
Jan 17, 2019

Leukemia, MDS Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • fludarabine phosphate
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Feb 17, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);

Completed
Has Results
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Erlotinib Hydrochloride
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Dec 18, 2019

B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic

Terminated
  • B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
  • +16 more
  • Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 28, 2021

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +19 more
    • umbilical cord blood transplantation
    • +7 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Feb 27, 2019

    Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)

    Active, not recruiting
    Has Results
    • Leukemia
    • Birmingham, Alabama
    • +184 more
    Feb 4, 2022

    Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

    Recruiting
    • Brain and Central Nervous System Tumors
    • +8 more
    • 3'-deoxy-3'-[18F]fluorothymidine
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Mar 30, 2022

    Acute Myeloid Leukemia Trial (ABBV-787)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 29, 2023

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

    Active, not recruiting
    • Acute Leukemia
    • +3 more
    • cytogenetic analysis
    • La Jolla, California
    • +136 more
    Aug 16, 2021

    Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

    Recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia
    • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
    • Best-Available Therapy(BAT) Regimen
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Oct 10, 2023

    MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

    Recruiting
    • Myelodysplastic Syndromes
    • +5 more
    • description of MDS pzatient cohort
    • Brest, France
      Chu Brest
    Oct 27, 2022